JP Morgan Chase
WINT

JP Morgan Chase’s Windtree Therapeutics Inc WINT Stock Holding History

JP Morgan Chase’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$5K – 5275
2016
Q3 		$5K Buy
+2,000
New +$4.35K ﹤0.01% 4377
2015
Q2 		– Sell
-2,528
Closed -$42K – 4305
2015
Q1 		$42K Buy
+2,528
New +$49.8K ﹤0.01% 3947
2014
Q2 		– Sell
-2,873
Closed -$86K – 3700
2014
Q1 		$86K Buy
+2,873
New +$96.7K ﹤0.01% 3494
2013
Q3 		– Sell
-2,967
Closed -$63K – 4519
2013
Q2 		$63K Buy
+2,967
New +$73.1K ﹤0.01% 4244

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

JP Morgan Chase's WINT Position: Q4 2016 in Review

JP Morgan Chase sold out of Windtree Therapeutics Inc (WINT) in Q4 2016, closing a stake of 2,000 shares — an estimated $5K sold.

JP Morgan Chase first reported a position in WINT in Q2 2013 and held it in 4 quarters. The position peaked at $86K in Q1 2014. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

  • JP Morgan Chase reported no remaining Windtree Therapeutics Inc position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 2,000 Windtree Therapeutics Inc shares in Q4 2016, an estimated $5K.
  • JP Morgan Chase first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 4 quarters.
  • JP Morgan Chase's Windtree Therapeutics Inc position peaked at $86K in Q1 2014.
  • 31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.